Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting

Rajoriya, Vaibhav; Gupta, Ravikant; Vengurlekar, Sudha; Surendra Singh, Upama

doi:10.1016/j.ijpharm.2024.123986

International Journal of Pharmaceutics

2024

DOI: 10.1016/j.ijpharm.2024.123986

|View full text |Cite

Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting

Vaibhav Rajoriya,

Ravikant Gupta,

Sudha Vengurlekar

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 136 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency

Yang,

Zhang,

Lai

et al. 2025

Journal of Colloid and Interface Science

View full text Add to dashboard Cite

A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency

Yang,

Zhang,

Lai

et al. 2025

Journal of Colloid and Interface Science

View full text Add to dashboard Cite

Nanocarriers for nutraceutical delivery: A miniaturized revolution in health

Sawant,

Nikam,

Roy

et al. 2024

Nano-Structures & Nano-Objects

View full text Add to dashboard Cite

Emerging trends in pharmacological and therapeutic potential of glycyrrhizic acids: Traditional and nanotechnological approach

Jurel,

Bahadur,

Bajpai

2024

Pharmacological Research - Modern Chinese Medicine

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting

Cited by 3 publications

References 136 publications

A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency

A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency

Nanocarriers for nutraceutical delivery: A miniaturized revolution in health

Emerging trends in pharmacological and therapeutic potential of glycyrrhizic acids: Traditional and nanotechnological approach

Contact Info

Product

Resources

About